A three-arm, Randomised Controlled Trial of the effectiveness and cost-effectiveness of adjunctive medication management and contingency management to enhance adherence to medications for relapse prevention in alcohol dependence (ADAM).
Change Grow Live is working with academics and clinical experts from across the country to support this important study into the treatment of alcohol dependence. Providing effective treatment, including the prescribing of acamprosate (Campral), helps those who have, problems with alcohol reduce the risk of drinking again. A team of researchers led by Professor Colin Drummond, King's College London, have designed interventions delivered by pharmacists via a central telephone service to help support people to take acamprosate as it is prescribed. The ADAM study is a randomised controlled trial to determine the efficacy of medication management with and without contingency management to increase adherence to acamprosate compared to treatment as usual.
A number of Change Grow Live services in Birmingham, Hull, London, Rotherham and Scunthorpe are offering people undergoing treatment for alcohol problems the opportunity to participate in this groundbreaking research. With their agreement, those suitable to participate in the study will be put in contact with the research team.
Researchers: Colin Drummond, et al.